Auriculilla derecha que semeja tumor residual en un mesotelioma tratado con pleuropericardioneumonectomía, quimioterapia e IGRT.
Right atrial appendage resembling residual tumor in mesothelioma treated with extrapleural pneumonectomy, chemotherapy and IGRT.
Barra lateral del artículo
PDF
FLIP
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Contenido principal del artículo
.
Descargas
Detalles del artículo
Yanagawa J, Rusch V. Surgical management of malignant pleural mesothelioma. Thorac Surg Clin [online] 2013 [cited 2013 Jun 19];23(1):73-87, vi.
Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg [online] 2009 [cited 2013 Jun 19];21(2):172-6.
Baldini EH, Recht A, Strauss GM, DeCamp MM Jr, Swanson SJ, Liptay MJ, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg [online] 1997;63(2):334-8.
Gerbaudo VH, Katz SI, Nowak AK, Francis RJ. Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging. PET Clin. 2011;6(3):275-97.
Nguyen BD. PET/CT Demonstration and Monitoring of Thoracic and Abdominal Wall Mesothelioma. Clin Nucl Med. 2013;1-4.
Zahid I, Sharif S, Routledge T, Scarci M. What is the best way to diagnose and stage malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg. 2011;12(2):254-9.
Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41(1):1-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11750145.
Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21(2):111-20.
Yamamuro M, Gerbaudo VH, Gill RR, Jacobson FL, Sugarbaker DJ, Hatabu H. Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol. 2007;64(3):356-66.
Orcajo Rincón J, Alonso Farto JC, Rotger Regi A, Hernández Pérez R, Hualde AM, Pérez Aradas V. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy. Rev Esp Med Nucl. 2011;30(5):307-10.
Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20(2):215-20.
Fuccio C, Spinapolice EG, Ferretti A, Castellucci P, Marzola MC, Trifirò G, et al. (18)F-FDG-PET/CT in malignant mesothelioma. Biomed Pharmacother. 2013;8-11.
Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18Ffluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
Sterman DH, Albelda SM. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma. Respirology. 2005;10(3):266-83.
Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. J Nucl med. 2007;48(10):1662-9.
Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31(5):1287-305.
Zöphel K, Kotzerke J. High intraindividual variability of global myocardial 18F-FDG uptake over time. J Nucl Med. 2008;49(9):1570.
Israel O, Weiler-Sagie M, Rispler S, Bar-Shalom R, Frenkel A, Keidar Z, et al. PET/CT quantitation of the effect of patientrelated factors on cardiac 18F-FDG uptake. J Nucl Med. 2007;48(2):234-9.
Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography.
Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, et al. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thor Oncol. 2009;4(12):1480-4.
